https://www.selleckchem.com/pr....oducts/fluoxetine.ht
Among these new users, their median cumulative duration of prescription was 1 year (interquartile range 0.4-2.3). During follow-up, 354 patients developed ESKD and 216 died before ESKD. The adjusted HRs associated with PPI prescription were 1.74 (95% CI, 1.26-2.4 for ESKD and 2.42 (95% CI, 1.73-3.39) for all-cause mortality. Over the first 3 years of follow-up, 211 AKI events had occurred. The adjusted HR for AKI associated with PPI prescription was 2.89 (95% CI, 1.91-4.38). Long-term PPI prescription was common in CKD patients. Ou